Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
Gilead Sciences
Hope S Rugo; Aditya Bardia; Frederik Marmé; Javier Cortés; Peter Schmid; Delphine Loirat; Olivier Trédan; Eva Ciruelos; Florence Dalenc; Patricia Gómez Pardo; Komal L Jhaveri; Rosemary Delaney; Theresa Valdez; Hao Wang; Monica Motwani; Oh Kyu Yoon; Wendy Verret; Sara M Tolaney